InsidersTradesSigma
Follow the Camurus AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Camurus AB has logged 8 reports. Market capitalisation: €36.6bn. The latest transaction was disclosed on 10 August 2026 (Sale). Among the most active insiders: Richard Jameson. The full history is openly available.
8
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€720,663
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Camurus AB Strong Buy (bullish), based on 8 analysts. Average price target: SEK 776.75.
15Σ signal
Fundamental score
Ranked 8,468 of 28,752 companies
61.8
score / 100
Value34
Quality90
FCF yld1.9%
Earn yld2.0%
EV/EBITDA39.0x
ROE16%
Gross mgn93%
Net mgn32%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 August 2026
Declarations8 total
5,800 shares@ €48.1476AktieISIN SE0007692850FI:csv-814ed16883072a60f5df
1,000 shares0TeckningsoptionFI:A003S458-2
4,000 shares0AktieISIN SE0007692850FI:A003S567-1
16,000 shares0AktieISIN SE0007692850FI:A003P837-1
16,000 shares0AktieISIN SE0007692850FI:A003P645-1
16,725 shares@ SEK 180.00100.0% of flowAktieISIN SE0007692850FI:A001P414-1
8,000 shares@ SEK 179.28100.0% of flowAktieISIN SE0007692850FI:A001P406-1
43,600 shares0AktieISIN SE0007692850FI:A001P326-1
8 of 8 declarations
About Camurus AB
Camurus AB is a Swedish pharmaceutical company focused on developing innovative treatments for chronic diseases. It is listed on the Stockholm Stock Exchange (XSTO).